data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Verve Therapeutics
(NASDAQ:VERV)
$15.63
0.35[2.29%]
At close: Jul 1
$15.63
00
After Hours: 4:04PM EDT
Day High/Low15.2 - 16.01
52 Week High/Low10.7 - 78
Open / Close15.31 / 15.63
Float / Outstanding20.7M / 48.7M
Vol / Avg.485.2K / 693.6K
Mkt Cap760.6M
P/E-
50d Avg. Price14.26
Div / Yield-
Payout Ratio-
EPS-0.62
Total Float20.7M

Verve Therapeutics (NASDAQ:VERV), Quotes and News Summary

Verve Therapeutics (NASDAQ: VERV)

Day High/Low15.2 - 16.01
52 Week High/Low10.7 - 78
Open / Close15.31 / 15.63
Float / Outstanding20.7M / 48.7M
Vol / Avg.485.2K / 693.6K
Mkt Cap760.6M
P/E-
50d Avg. Price14.26
Div / Yield-
Payout Ratio-
EPS-0.62
Total Float20.7M
Benzinga - 1 day ago
Benzinga - Jun 17, 2022, 3:31PM
Benzinga - Jun 17, 2022, 5:26AM
Benzinga - May 10, 2022, 7:03AM
Benzinga - May 10, 2022, 6:52AM
Benzinga - May 9, 2022, 6:41AM
Benzinga - Apr 4, 2022, 6:35AM
Benzinga - Mar 14, 2022, 6:31AM
Benzinga - Feb 18, 2022, 4:52AM
Benzinga - Jan 10, 2022, 6:34AM
Benzinga - Nov 29, 2021, 8:09AM
Benzinga - Nov 10, 2021, 6:39AM
Benzinga - Nov 9, 2021, 6:39AM
load more
Sector: Health Care.Industry: Biotechnology
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-11
REV
Q1 2022Est.ActualSurprise
EPS-0.620
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Verve Therapeutics Questions & Answers

Q
How do I buy Verve Therapeutics (VERV) stock?
A

You can purchase shares of Verve Therapeutics (NASDAQ: VERV) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Verve Therapeutics's (VERV) competitors?
Q
What is the target price for Verve Therapeutics (VERV) stock?
A

The latest price target for Verve Therapeutics (NASDAQ: VERV) was reported by BMO Capital on Friday, June 17, 2022. The analyst firm set a price target for 48.00 expecting VERV to rise to within 12 months (a possible 207.10% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Verve Therapeutics (VERV)?
A

The stock price for Verve Therapeutics (NASDAQ: VERV) is $15.63 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Verve Therapeutics (VERV) pay a dividend?
A

There are no upcoming dividends for Verve Therapeutics.

Q
When is Verve Therapeutics (NASDAQ:VERV) reporting earnings?
A

Verve Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.

Q
Is Verve Therapeutics (VERV) going to split?
A

There is no upcoming split for Verve Therapeutics.

Q
What sector and industry does Verve Therapeutics (VERV) operate in?
A

Verve Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.